Astal Laboratories schedules 33rd AGM for September 29, 2026

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Astal Laboratories schedules its 33rd AGM for September 29, 2026
  • Remote e-voting window opens on September 26 and closes on September 28
  • Board approved FY26 financial results in September 4 meeting
  • Share transfer books close from September 23 to September 29
powered bylight_fuzz_icon
49727434

*this image is generated using AI for illustrative purposes only.

Astal Laboratories has scheduled its 33rd Annual General Meeting for September 29, 2026. The meeting will be held via video conference or other audio-visual means.

The company confirmed that shareholders can cast their votes electronically between September 26 and September 28, 2026. The board previously approved the financial results for FY26 during its session on September 4, 2026.

Key Outcomes

The board approved several key governance and compliance items during its session.

Agenda Item Status / Details
Financial Results Approved for FY ended March 31, 2026
Cost Auditor M/s Avnesh Jain & Co. appointed for FY27
AGM Date September 29, 2026, at 1:30 pm
Voting Mode Video Conferencing / OAVM
Scrutinizer M/s Mahendra Khandelwal & Co. appointed

E-Voting Schedule

Shareholders eligible to vote must be on the register of members as of the cut-off date, Tuesday, September 22, 2026. The remote e-voting process begins on Saturday, September 26, 2026, at 9:00 am and concludes on Monday, September 28, 2026, at 5:00 pm.

AGM Logistics

The 33rd Annual General Meeting is scheduled for Tuesday, September 29, 2026, at 1:30 pm. The register of members and share transfer books will remain closed from Wednesday, September 23, 2026, to Tuesday, September 29, 2026.

M/s Mahendra Khandelwal & Co., Practicing Company Secretary, was appointed as the scrutinizer to oversee remote e-voting and e-voting during the AGM.

The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Astal Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-0.31%-4.50%-14.32%-3.94%-14.06%0.0%

What key strategic initiatives or capital allocation plans is Astal Laboratories' management expected to announce or discuss at the AGM that could impact shareholder value?

How have Astal Laboratories' FY26 financial results compared to industry peers, and what does this signal about the company's competitive positioning going into FY27?

Will the appointment of M/s Avnesh Jain & Co. as Cost Auditor for FY27 lead to any significant changes in the company's cost structure or operational efficiency strategies?

Astal Laboratories Q1 Results: Unaudited financials filed for June 2026

scanx
Reviewed by
Naman SScanX News Team
Key Highlights

Astal Laboratories Limited filed its unaudited Q1FY26 standalone and consolidated financial results with BSE. The company confirmed publication in major newspapers on August 15, 2026, adhering to SEBI LODR Regulation 47. No specific financial figures were disclosed in this procedural filing.

powered bylight_fuzz_icon
48422872

*this image is generated using AI for illustrative purposes only.

Astal Laboratories Limited has submitted its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, to the Bombay Stock Exchange. The filing serves as a formal notification of the company’s compliance with disclosure norms under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company informed the exchange that the extract of the financial results was published in the August 15, 2026 editions of The Financial Express and The Business Standard (English) and The Jansatta (Hindi). This publication fulfills the requirement under Regulation 47 of the SEBI LODR Regulations.

Regulatory Compliance

The submission was made pursuant to Regulation 30 of the SEBI LODR Regulations, which mandates timely disclosure of financial performance to listed entities. Astal Laboratories provided copies of the relevant newspaper publications to the exchange for record-keeping purposes.

Mahendra Kumar, Company Secretary and Compliance Officer at Astal Laboratories, signed the submission on August 16, 2026. The company previously operated under the name Macro International Limited.

What the Numbers Show

The current filing is a procedural notice confirming the publication of financial results. It does not contain specific financial metrics such as revenue, profit, or cash flow figures. Investors must refer to the full detailed format filed with the stock exchange or the published newspaper extracts for granular financial data.

Historical Stock Returns for Astal Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-0.31%-4.50%-14.32%-3.94%-14.06%0.0%

How will the upcoming release of audited annual results impact Astal Laboratories' stock valuation compared to these unaudited quarterly figures?

What strategic initiatives is Astal Laboratories prioritizing to drive revenue growth in the pharmaceutical sector following its rebranding from Macro International?

How might changes in SEBI's LODR regulations affect the compliance costs and reporting timelines for mid-cap listed entities like Astal Laboratories?

More News on Astal Laboratories

1 Year Returns:-14.06%